Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

When I lost weight on WW, I devoted all of my time to the program and I was successful. It was when life got hard that the ...

Plasma injections are in. But is L.A.'s 'natural ... As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, Bookless' DIY approach highlights the lengths some are willing ...

Tirzepatide, sold under the brand names Zepbound and Mounjaro, is a prescription medication that works for weight loss by reducing appetite and increasing satiety. Administered as a once-weekly ...

She works only with tirzepatide — the drug behind Zepbound that uses both GIP and ... her patients to figure out the amount and schedules injections as needed. “Not all of medicine is science ...